Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Osteonecrosis of the jaw"" wg kryterium: Temat


Tytuł:
The trend of dental check-up and prevalence of dental complications following the use of bone modifying agents in patients with metastatic breast and prostate cancer: analysis of data from the Korean National Health Insurance Service.
Autorzy:
Lim AR; Division of Medical Oncology, Department of Internal Medicine, Korea University Anam Hospital, Korea University College of Medicine, 73, Goryeodae-ro, Seongbuk-gu, 02841, Seoul, Korea.
Park W; Department of Advanced General Dentistry, College of Dentistry, Yonsei University, Seoul, Korea.
Moon SJ; Department of Biostatistics, Korea University College of Medicine, Seoul, Korea.
Kim MS; Department of Biostatistics, Korea University College of Medicine, Seoul, Korea.
Lee S; Division of Medical Oncology, Department of Internal Medicine, Korea University Anam Hospital, Korea University College of Medicine, 73, Goryeodae-ro, Seongbuk-gu, 02841, Seoul, Korea. Soohyeon_.
Pokaż więcej
Źródło:
BMC health services research [BMC Health Serv Res] 2024 Apr 02; Vol. 24 (1), pp. 412. Date of Electronic Publication: 2024 Apr 02.
Typ publikacji:
Journal Article
MeSH Terms:
Bisphosphonate-Associated Osteonecrosis of the Jaw*/diagnosis
Bisphosphonate-Associated Osteonecrosis of the Jaw*/etiology
Bisphosphonate-Associated Osteonecrosis of the Jaw*/therapy
Bone Density Conservation Agents*/adverse effects
Prostatic Neoplasms*/drug therapy
Surgeons*
Male ; Humans ; Prevalence ; National Health Programs ; Republic of Korea/epidemiology ; Diphosphonates/adverse effects
Czasopismo naukowe
Tytuł:
Sclerotic bone: a sign of bone reaction in patients with medication related osteonecrosis of the jaw.
Autorzy:
Obermeier KT; Department of Oral and Maxillofacial Surgery and Facial Plastic Surgery, Ludwig-Maximilians-University (LMU), Lindwurmstrasse 2a, 80337, Munich, Germany.
Dewenter I; Department of Oral and Maxillofacial Surgery and Facial Plastic Surgery, Ludwig-Maximilians-University (LMU), Lindwurmstrasse 2a, 80337, Munich, Germany. .
Malenova Y; Department of Oral and Maxillofacial Surgery and Facial Plastic Surgery, Ludwig-Maximilians-University (LMU), Lindwurmstrasse 2a, 80337, Munich, Germany.
Fliefel R; Department of Oral and Maxillofacial Surgery and Facial Plastic Surgery, Ludwig-Maximilians-University (LMU), Lindwurmstrasse 2a, 80337, Munich, Germany.; Department of Orthopaedics and Trauma Surgery, Musculoskeletal University Center Munich (MUM), Ludwig-Maximilians-University (LMU), Fraunhoferstrasse 20, 82152, Planegg/Martinsried, Germany.; Department of Oral and Maxillofacial Surgery, Alexandria University, Alexandria, Egypt.
Kaeppler G; Department of Oral and Maxillofacial Surgery and Facial Plastic Surgery, Ludwig-Maximilians-University (LMU), Lindwurmstrasse 2a, 80337, Munich, Germany.
Otto S; Department of Oral and Maxillofacial Surgery and Facial Plastic Surgery, Ludwig-Maximilians-University (LMU), Lindwurmstrasse 2a, 80337, Munich, Germany.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Apr 04; Vol. 14 (1), pp. 7914. Date of Electronic Publication: 2024 Apr 04.
Typ publikacji:
Journal Article
MeSH Terms:
Bisphosphonate-Associated Osteonecrosis of the Jaw*/diagnostic imaging
Bisphosphonate-Associated Osteonecrosis of the Jaw*/surgery
Bisphosphonate-Associated Osteonecrosis of the Jaw*/drug therapy
Osteonecrosis*/chemically induced
Osteonecrosis*/diagnostic imaging
Osteonecrosis*/surgery
Bone Density Conservation Agents*/adverse effects
Humans ; Denosumab/adverse effects ; Retrospective Studies ; Diphosphonates/adverse effects ; Necrosis/chemically induced
Czasopismo naukowe
Tytuł:
Treatment of Medication-Related Osteonecrosis of the Jaws without Segmental Resections: A Case Series.
Autorzy:
Fernandes TL; Department of Dentistry, State University of Ponta Grossa (UEPG), Ponta Grossa, PR, Brazil.
Viezzer Fernandes B; Department of Dentistry, State University of Ponta Grossa (UEPG), Ponta Grossa, PR, Brazil.
Franco GCN; Department of Dentistry, State University of Ponta Grossa (UEPG), Ponta Grossa, PR, Brazil.
Pokaż więcej
Źródło:
The American journal of case reports [Am J Case Rep] 2024 Feb 26; Vol. 25, pp. e942980. Date of Electronic Publication: 2024 Feb 26.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Bone Density Conservation Agents*/adverse effects
Bisphosphonate-Associated Osteonecrosis of the Jaw*/surgery
Bisphosphonate-Associated Osteonecrosis of the Jaw*/etiology
Osteoporosis*/chemically induced
Osteoporosis*/complications
Osteoporosis*/drug therapy
Humans ; Female ; Aged ; Diphosphonates/adverse effects ; Neoplasm Recurrence, Local/complications ; Jaw
Czasopismo naukowe
Tytuł:
Physicians' awareness of medication-related osteonecrosis of the jaw in patients with osteoporosis.
Autorzy:
Supanumpar N; Faculty of Dentistry, Department of Oral and Maxillofacial Surgery, Chulalongkorn University, Bangkok, Thailand.
Pisarnturakit PP; Faculty of Dentistry, Department of Community Dentistry, Chulalongkorn University, Bangkok, Thailand.
Charatcharoenwitthaya N; Department of Medicine, Faculty of Medicine, Thammasat University, Pathum Thani, Thailand.
Subbalekha K; Faculty of Dentistry, Department of Oral and Maxillofacial Surgery, Chulalongkorn University, Bangkok, Thailand.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2024 Jan 26; Vol. 19 (1), pp. e0297500. Date of Electronic Publication: 2024 Jan 26 (Print Publication: 2024).
Typ publikacji:
Journal Article
MeSH Terms:
Bone Density Conservation Agents*/adverse effects
Bisphosphonate-Associated Osteonecrosis of the Jaw*/epidemiology
Bisphosphonate-Associated Osteonecrosis of the Jaw*/etiology
Bisphosphonate-Associated Osteonecrosis of the Jaw*/diagnosis
Osteoporosis*/complications
Physicians*
Humans ; Cross-Sectional Studies ; Diphosphonates/therapeutic use
Czasopismo naukowe
Tytuł:
A real-world study on the prevalence and risk factors of medication related osteonecrosis of the jaw in cancer patients with bone metastases treated with Denosumab.
Autorzy:
Bracchi P; Palliative Care, Pain Therapy and Rehabilitation Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.
Zecca E; Palliative Care, Pain Therapy and Rehabilitation Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.
Brunelli C; Palliative Care, Pain Therapy and Rehabilitation Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.
Miceli R; Biostatistics for Clinical Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.
Tinè G; Biostatistics for Clinical Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.
Maniezzo M; Odontostomatology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.
Lo Dico S; Palliative Care, Pain Therapy and Rehabilitation Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.
Caputo M; Palliative Care, Pain Therapy and Rehabilitation Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.
Shkodra M; Palliative Care, Pain Therapy and Rehabilitation Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Caraceni AT; Palliative Care, Pain Therapy and Rehabilitation Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.; Department of Clinical Sciences and Community Health, Università degli Studi di Milano, Milan, Italy.
Pokaż więcej
Źródło:
Cancer medicine [Cancer Med] 2023 Sep; Vol. 12 (17), pp. 18317-18326. Date of Electronic Publication: 2023 Aug 09.
Typ publikacji:
Observational Study; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Bone Density Conservation Agents*/adverse effects
Bisphosphonate-Associated Osteonecrosis of the Jaw*/epidemiology
Bisphosphonate-Associated Osteonecrosis of the Jaw*/etiology
Bone Neoplasms*/secondary
Male ; Middle Aged ; Humans ; Denosumab/adverse effects ; Prevalence ; Diphosphonates ; Angiogenesis Inhibitors/therapeutic use ; Risk Factors ; Hormones ; Retrospective Studies
Czasopismo naukowe
Tytuł:
Impact of beta-tricalcium phosphate on preventing tooth extraction-triggered bisphosphonate-related osteonecrosis of the jaw in rats.
Autorzy:
Funayama N; Department of Oral and Maxillofacial Surgery, Nara Medical University, 840 Shijo-cho, Kashihara-shi, Nara, 634-8521, Japan.
Yagyuu T; Department of Oral and Maxillofacial Surgery, Nara Medical University, 840 Shijo-cho, Kashihara-shi, Nara, 634-8521, Japan. .
Imada M; Department of Oral and Maxillofacial Surgery, Nara Medical University, 840 Shijo-cho, Kashihara-shi, Nara, 634-8521, Japan.
Ueyama Y; Department of Oral and Maxillofacial Surgery, Nara Medical University, 840 Shijo-cho, Kashihara-shi, Nara, 634-8521, Japan.
Nakagawa Y; Department of Oral and Maxillofacial Surgery, Nara Medical University, 840 Shijo-cho, Kashihara-shi, Nara, 634-8521, Japan.
Kirita T; Department of Oral and Maxillofacial Surgery, Nara Medical University, 840 Shijo-cho, Kashihara-shi, Nara, 634-8521, Japan.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2023 Sep 25; Vol. 13 (1), pp. 16032. Date of Electronic Publication: 2023 Sep 25.
Typ publikacji:
Journal Article
MeSH Terms:
Bisphosphonate-Associated Osteonecrosis of the Jaw*/etiology
Bisphosphonate-Associated Osteonecrosis of the Jaw*/prevention & control
Animals ; Rats ; Humans ; Dental Care ; Tooth Extraction/adverse effects ; Calcium Phosphates ; Zoledronic Acid
Czasopismo naukowe
Tytuł:
Medication-related osteonecrosis of the jaw without osteolysis on computed tomography: a retrospective and observational study.
Autorzy:
Sakamoto Y; Department of Dentistry and Oral Surgery, Kansai Medical University Medical Center, 10-15 Fumizono-Cho, Moriguchi, Osaka, 570-8507, Japan. .
Sawada S; Department of Dentistry and Oral Surgery and Oral Care, Kansai Medical University Hospital, Hirakata, Osaka, 573-1191, Japan.
Kojima Y; Department of Dentistry and Oral Surgery and Oral Care, Kansai Medical University Hospital, Hirakata, Osaka, 573-1191, Japan.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2023 Aug 09; Vol. 13 (1), pp. 12890. Date of Electronic Publication: 2023 Aug 09.
Typ publikacji:
Observational Study; Journal Article
MeSH Terms:
Bisphosphonate-Associated Osteonecrosis of the Jaw*/diagnostic imaging
Osteolysis*/diagnostic imaging
Osteolysis*/etiology
Bone Density Conservation Agents*/adverse effects
Humans ; Retrospective Studies ; Diphosphonates/adverse effects ; Tomography, X-Ray Computed ; Jaw
Czasopismo naukowe
Tytuł:
Identification of Potential Biomarkers and Small Molecule Drugs for Bisphosphonate-Related Osteonecrosis of the Jaw (BRONJ): An Integrated Bioinformatics Study Using Big Data.
Autorzy:
Balachandran K; Department of Craniofacial Diagnostics and Biosciences, Faculty of Dentistry, University Kebangsaan Malaysia, Jalan Raja Muda Abdul Aziz, Kuala Lumpur 50300, Malaysia.
Ramli R; Department of Oral and Maxillofacial Surgery, Faculty of Dentistry, Universiti Kebangsaan Malaysia, Kuala Lumpur 50300, Malaysia.
Karsani SA; Institute of Biological Sciences, Faculty of Science, Universiti Malaya, Kuala Lumpur 50603, Malaysia.
Abdul Rahman M; Department of Craniofacial Diagnostics and Biosciences, Faculty of Dentistry, University Kebangsaan Malaysia, Jalan Raja Muda Abdul Aziz, Kuala Lumpur 50300, Malaysia.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 May 11; Vol. 24 (10). Date of Electronic Publication: 2023 May 11.
Typ publikacji:
Journal Article
MeSH Terms:
Bisphosphonate-Associated Osteonecrosis of the Jaw*/diagnosis
Bisphosphonate-Associated Osteonecrosis of the Jaw*/drug therapy
Bisphosphonate-Associated Osteonecrosis of the Jaw*/etiology
Multiple Myeloma*/drug therapy
Bone Density Conservation Agents*/therapeutic use
Humans ; Big Data ; Molecular Docking Simulation ; Biomarkers ; Diphosphonates/adverse effects
Czasopismo naukowe
Tytuł:
Dietary nitrate improves jaw bone remodelling in zoledronate-treated mice.
Autorzy:
Pan W; Salivary Gland Disease Centre and Beijing Key Laboratory of Tooth Regeneration and Function Reconstruction, School of Stomatology, Beijing Laboratory of Oral Health, Capital Medical University, Beijing, China.; Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Capital Medical University, Beijing, China.
Gu J; Salivary Gland Disease Centre and Beijing Key Laboratory of Tooth Regeneration and Function Reconstruction, School of Stomatology, Beijing Laboratory of Oral Health, Capital Medical University, Beijing, China.; Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Capital Medical University, Beijing, China.
Xu S; Salivary Gland Disease Centre and Beijing Key Laboratory of Tooth Regeneration and Function Reconstruction, School of Stomatology, Beijing Laboratory of Oral Health, Capital Medical University, Beijing, China.; Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Capital Medical University, Beijing, China.
Zhang C; Salivary Gland Disease Centre and Beijing Key Laboratory of Tooth Regeneration and Function Reconstruction, School of Stomatology, Beijing Laboratory of Oral Health, Capital Medical University, Beijing, China.; Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Capital Medical University, Beijing, China.; Immunology Research Centre for Oral and Systemic Health, Beijing Friendship Hospital, Capital Medical University, Beijing, China.; Laboratory for Oral and General Health Integration and Translation, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Wang J; Salivary Gland Disease Centre and Beijing Key Laboratory of Tooth Regeneration and Function Reconstruction, School of Stomatology, Beijing Laboratory of Oral Health, Capital Medical University, Beijing, China.; Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Capital Medical University, Beijing, China.
Wang S; Salivary Gland Disease Centre and Beijing Key Laboratory of Tooth Regeneration and Function Reconstruction, School of Stomatology, Beijing Laboratory of Oral Health, Capital Medical University, Beijing, China.; Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Capital Medical University, Beijing, China.; Immunology Research Centre for Oral and Systemic Health, Beijing Friendship Hospital, Capital Medical University, Beijing, China.; Laboratory for Oral and General Health Integration and Translation, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.; Research Units of Tooth Development and Regeneration, Chinese Academy of Medical Sciences, Beijing, China.
Xu J; Salivary Gland Disease Centre and Beijing Key Laboratory of Tooth Regeneration and Function Reconstruction, School of Stomatology, Beijing Laboratory of Oral Health, Capital Medical University, Beijing, China.; Immunology Research Centre for Oral and Systemic Health, Beijing Friendship Hospital, Capital Medical University, Beijing, China.; Laboratory for Oral and General Health Integration and Translation, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.; Research Units of Tooth Development and Regeneration, Chinese Academy of Medical Sciences, Beijing, China.; Department of Periodontics, Beijing Stomatological Hospital, Capital Medical University School of Stomatology, Beijing, China.; Shanghai Stomatological Hospital & School of Stomatology, Fudan University, Shanghai, China.
Pokaż więcej
Źródło:
Cell proliferation [Cell Prolif] 2023 Jul; Vol. 56 (7), pp. e13395. Date of Electronic Publication: 2023 Feb 21.
Typ publikacji:
Journal Article
MeSH Terms:
Bisphosphonate-Associated Osteonecrosis of the Jaw*/etiology
Bisphosphonate-Associated Osteonecrosis of the Jaw*/pathology
Bisphosphonate-Associated Osteonecrosis of the Jaw*/therapy
Bone Density Conservation Agents*
Mice ; Animals ; Zoledronic Acid/pharmacology ; Nitrates ; Diphosphonates/adverse effects ; Disease Models, Animal ; Bone Remodeling ; Lipids
Czasopismo naukowe
Tytuł:
In Vitro Cytotoxicity of Antiresorptive and Antiangiogenic Compounds on Oral Tissues Contributing to MRONJ: Systematic Review.
Autorzy:
Guirguis RH; Melbourne Dental School, The University of Melbourne, 720 Swanston Street, Carlton, VIC 3053, Australia.
Tan LP; Melbourne Dental School, The University of Melbourne, 720 Swanston Street, Carlton, VIC 3053, Australia.
Hicks RM; Melbourne Dental School, The University of Melbourne, 720 Swanston Street, Carlton, VIC 3053, Australia.
Hasan A; Melbourne Dental School, The University of Melbourne, 720 Swanston Street, Carlton, VIC 3053, Australia.
Duong TD; Melbourne Dental School, The University of Melbourne, 720 Swanston Street, Carlton, VIC 3053, Australia.
Hu X; Melbourne Dental School, The University of Melbourne, 720 Swanston Street, Carlton, VIC 3053, Australia.
Hng JYS; Melbourne Dental School, The University of Melbourne, 720 Swanston Street, Carlton, VIC 3053, Australia.
Hadi MH; Melbourne Dental School, The University of Melbourne, 720 Swanston Street, Carlton, VIC 3053, Australia.
Owuama HC; Melbourne Dental School, The University of Melbourne, 720 Swanston Street, Carlton, VIC 3053, Australia.
Matthyssen T; Melbourne Dental School, The University of Melbourne, 720 Swanston Street, Carlton, VIC 3053, Australia.
McCullough M; Melbourne Dental School, The University of Melbourne, 720 Swanston Street, Carlton, VIC 3053, Australia.
Canfora F; Department of Neuroscience, Reproductive Sciences and Dentistry, University of Naples Federico II, 80131 Naples, Italy.
Paolini R; Melbourne Dental School, The University of Melbourne, 720 Swanston Street, Carlton, VIC 3053, Australia.
Celentano A; Melbourne Dental School, The University of Melbourne, 720 Swanston Street, Carlton, VIC 3053, Australia.
Pokaż więcej
Źródło:
Biomolecules [Biomolecules] 2023 Jun 10; Vol. 13 (6). Date of Electronic Publication: 2023 Jun 10.
Typ publikacji:
Systematic Review; Journal Article; Review
MeSH Terms:
Bone Density Conservation Agents*/adverse effects
Bisphosphonate-Associated Osteonecrosis of the Jaw*/drug therapy
Bisphosphonate-Associated Osteonecrosis of the Jaw*/etiology
Humans ; Denosumab/adverse effects ; Diphosphonates/pharmacology ; Diphosphonates/therapeutic use ; Zoledronic Acid ; Angiogenesis Inhibitors/pharmacology ; Angiogenesis Inhibitors/therapeutic use
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies